90698 Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 

Dated: November 8, 2024. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2024–26783 Filed 11–15–24; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–25AW; Docket No. CDC–2024– 

0094] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National 

Concussion Surveillance System. This 

data collection is designed to allow CDC 

to calculate the prevalence and 

incidence of traumatic brain injuries 

(TBI) for both adults and children, and 

the circumstances related to TBIs 

occurring in the preceding year. 

DATES: CDC must receive written 

comments on or before January 17, 

2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0094 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Under the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3501–3520), 

federal agencies must obtain approval 

from the Office of Management and 

Budget (OMB) for each collection of 

information they conduct or sponsor. In 

addition, the PRA also requires federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each new proposed 

collection, each proposed extension of 

existing collection of information, and 

each reinstatement of previously 

approved information collection before 

submitting the collection to the OMB for 

approval. To comply with this 

requirement, we are publishing this 

notice of a proposed data collection as 

described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Concussion Surveillance 

System—New—National Center for 

Injury Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

In 2014, an Institute of Medicine 

(IOM) report titled ‘‘Sports-Related 

Concussions in Youth: Improving the 

Science, Changing the Culture,’’ 

recommended that the U.S. Centers for 

Disease Control and Prevention (CDC) 

establish and oversee a national 

surveillance system to accurately 

determine the incidence of sportsrelated concussions [i.e., mild traumatic 

brain injuries, or TBIs], including those 

in youth ages five to 21. The report 

further recommended that the cause, 

nature, and extent of the concussive 

injury also should be collected, 

including the sport or activity, level of 

competition, and signs and symptoms 

consistent with a concussion. The IOM 

recommendation was made because 

there were significant gaps in 

understanding of TBI, including 

concussion, incidence and prevalence 

estimates. Current non-fatal TBI 

surveillance estimates typically utilize 

emergency department (ED) or 

hospitalization-focused data sources. 

But these sources cannot account for 

injuries that go untreated or injuries 

diagnosed in primary care, urgent care, 

or specialty care settings, potentially 

missing information on millions of TBIs 

sustained each year. Without an 

accurate understanding of the burden, 

trends, and characteristics of these 

injuries, it is challenging to design or 

focus effective prevention programs, 

policies, or practices. The consequences 

from TBI are staggering, with many 

resulting in intensive and long-term care 

needs. This data collection could help 

fill significant knowledge gaps and 

inform prevention efforts across the 

country. 

The purpose of this data collection is 

to calculate the 12-month prevalence 

and incidence of TBI for both adults and 

children, and the circumstances related 

to TBIs occurring in the preceding 12 

months. The data collection instrument 

is largely based on the instrument used 

during the pilot that utilized cognitive 

testing prior to deployment. Data 

collected will include reports of head 

injuries experienced in the preceding 12 

months, and the most recent head injury 

reported will be assessed for symptoms 

of TBI. We will also query respondents 

who sustained a head injury regarding 

the mechanism of injury (cause) and 

circumstances related to the TBI, 

medical care received, impact on social 

and school functioning, and information 

related to returning to work/school/ 

play. 

Data will be analyzed to produce 

nationally representative 12-month 

incidence and prevalence estimates of 

non-fatal TBI in children (ages 5–17) 

and adults. Data collected are likely to 

be used by state and local governments, 

researchers, voluntary health 

organizations, physicians, health 

educators, workplace wellness 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 90699 

programs, healthcare systems, and 

professional and advocacy organizations 

to guide program investments, provide 

up-to-date information on symptom 

presentation, healthcare utilization 

patterns, and patient recovery among 

others, and to provide information on 

prevention of TBI. 

Data obtained from this data 

collection are not available from 

currently existing databases, and the 

data needed for analysis cannot be 

added to existing data collection 

processes. This data collection will 

occur over three years. After each data 

collection year, findings will be 

reviewed to identify potential 

modifications to the methodology and 

survey for following year collection. 

Depending on the nature and scope of 

the improvements, a change request or 

a Revision package will be submitted to 

OMB for review and approval. CDC 

requests OMB approval for an estimated 

5,656 annual burden hours. There is no 

cost to respondents other than their time 

to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Individuals and Households ....... Initial Invitation Letter .............................. 57,405 1 1/60 957 

Reminder Postcard ................................. 53,312 1 1/60 889 

Final Reminder Letter ............................. 50,583 1 1/60 843 

Text Message Reminder ......................... 27,696 1 1/60 462 

Screener .................................................. 10,058 1 4/60 671 

Survey, web ............................................ 8,682 1 11/60 1592 

Survey, phone ......................................... 1,318 1 11/60 242 

Total .................................... ................................................................. ........................ ........................ ........................ 5,656 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–26777 Filed 11–15–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Advisory 

Committee on Breast Cancer in Young 

Women 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), within the 

Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Advisory 

Committee on Breast Cancer in Young 

Women (ACBCYW). The ACBCYW 

consists of up to 15 experts in fields 

associated with breast cancer, disease 

prevention, early detection, diagnosis, 

public health, social marketing, genetic 

screening and counseling, treatment, 

rehabilitation, palliative care, and 

survivorship in young women, or in 

related disciplines with a specific focus 

on young women. 

DATES: Nominations for membership on 

the ACBCYW must be received no later 

than December 16, 2024. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

mailed to Kimberly E. Smith, M.B.A., 

M.H.A., c/o ACBCYW Secretariat, 

Centers for Disease Control and 

Prevention, 3719 North Peachtree Road, 

Building 100, Chamblee, Georgia 30341 

or emailed to acbcyw@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly E. Smith, M.B.A., M.H.A., 

Designated Federal Officer, National 

Center for Chronic Disease Prevention 

and Health Promotion, Centers for 

Disease Control and Prevention, 4770 

Buford Highway NE, Mailstop S107–4, 

Atlanta, Georgia 30341. Telephone: 

(404) 498–0073; Email: acbcyw@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are sought for individuals 

who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the objectives of 

the Advisory Committee on Breast 

Cancer in Young Women (ACBCYW). 

Nominees will be selected based on 

expertise in the fields of breast health, 

breast cancer, disease prevention and 

risk reduction, survivorship (including 

metastatic breast cancer), hereditary 

breast and ovarian cancer, or in related 

disciplines with a specific focus on 

young women. Persons with personal 

experience with early onset breast 

cancer are also eligible to apply. This 

includes but may not be limited to 

breast cancer survivors 45 years of age 

or younger, and caregivers of said 

persons. Federal employees will not be 

considered for membership. Members 

may be invited to serve up to four-year 

terms. Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ACBCYW 

objectives (https://www.cdc.gov/breastcancer/php/advisory-committee/). 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on Federal workgroups or 

prior experience serving on a Federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning of and annually during their 

terms. The Centers for Disease Control 

and Prevention (CDC) reviews potential 

candidates for ACBCYW membership 

each year and provides a slate of 


lotter on DSK11XQN23PROD with NOTICES1